The most recent programs for the Drugs (Pharmaceuticals) Tag http://www.c-spanvideo.org/browse?topic=1103 en-US Copyright 2013, National Cable Satellite Corporation info@c-spanarchives.org (National Cable Satellite Corporation) info@c-spanarchives.org (National Cable Satellite Corporation) Sat, 20 Apr 2013 00:00:00 GMT Sun, 19 May 2013 02:47:59 GMT Anna Edney talked about the congressional investigation into compounding pharmacies, including the role of the U.S. Food and Drug Administration (FDA) in regulating these pharmacies. A report released by House Democrats found gaps in the oversight of compounding pharmacies across the country. Ms. Edney also responded to telephone calls and electronic communications. A compounding pharmacy is one in which a licensed pharmacist combines or mixes ingredients for a prescription, creating a medication that is tailored to the needs of an individual, but is not necessarily approved by the FDA. http://www.c-spanvideo.org/program/312269-5 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/312269-5 Sat, 20 Apr 2013 00:00:00 GMT Joy Lovelace testified on the meningitis outbreak earlier in 2012 that killed her husband, Eddie Lovelace, who contracted the disease from a tainted injection. The outbreak was linked to 32 deaths in 19 states, and sickened 440 others, and was traced to a Massachusetts-based pharmacy that manufactured the shots. Ms. Lovelace in her testimony said that no one called to tell her the cause of her husband's death; she found out through the press. http://www.c-spanvideo.org/program/309397-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/309397-1 Sat, 20 Apr 2013 00:00:00 GMT Barry Cadden invoked his Fifth Amendment rights and would not testify at a hearing on the meningitis outbreak earlier in 2012 that was linked to 32 deaths in 19 states, and sickened 440 others. The outbreak was traced to his Massachusetts-based pharmacy that manufactured the contaminated injections. http://www.c-spanvideo.org/program/309397-2 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/309397-2 Sat, 20 Apr 2013 00:00:00 GMT Tom Kubic made closing remarks at a conference on counterfeit prescription drugs. http://www.c-spanvideo.org/program/308446-8 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/308446-8 Sat, 20 Apr 2013 00:00:00 GMT Margaret Hamburg gave the keynote address at a conference on counterfeit prescription drugs. She talked about a new campaign to increase consumer and physician awareness of the counterfeit problem. http://www.c-spanvideo.org/program/308446-7 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/308446-7 Sat, 20 Apr 2013 00:00:00 GMT Panelists talked about international efforts to investigate counterfeit prescription drug operations. Topics included the difficulties of tracking counterfeit drug shipments and the money involved. This was part of the Partnership for Safe Medicines (PSM) Third Annual Counterfeit Drug Conference, held at the National Press Club. http://www.c-spanvideo.org/program/308446-6 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/308446-6 Sat, 20 Apr 2013 00:00:00 GMT Panelists discussed drug safety and security, including the impact of counterfeit drugs on the industry. They also responded to questions from the audience. http://www.c-spanvideo.org/program/308446-5 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/308446-5 Sat, 20 Apr 2013 00:00:00 GMT John Roth, Director of the U.S. Food and Drug Administration's Office of Criminal Investigations talked about the resources at FDA's disposal for combating counterfeit drugs, the criteria for an investigation, and the processes involved. http://www.c-spanvideo.org/program/308446-4 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/308446-4 Sat, 20 Apr 2013 00:00:00 GMT Panelists talked about the need for technical solutions to the counterfeit drug problem, and the standardization of those solutions. They also responded to questions from the audience. http://www.c-spanvideo.org/program/308446-3 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/308446-3 Sat, 20 Apr 2013 00:00:00 GMT Panelists talked about the origins of online counterfeit drug sales and the reasons behind increases in sales. They also responded to questions from the audience. http://www.c-spanvideo.org/program/308446-2 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/308446-2 Sat, 20 Apr 2013 00:00:00 GMT Scott Williams and Tim Mackey presented their research on counterfeit drugs. http://www.c-spanvideo.org/program/308446-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/308446-1 Sat, 20 Apr 2013 00:00:00 GMT Investigative journalist Doug Fine looks at the financial benefits of legalizing cannabis, which he argues would add close to $100 billion to our economy. He showed slides during his presentation and then responded to questions from members of the audience at Harborside Health Center in Oakland, California. http://www.c-spanvideo.org/program/308028-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/308028-1 Sat, 20 Apr 2013 00:00:00 GMT Using personal stories of adults who were medicated as children, Ms. Barnett explores the debate over prescribing psychiatric drugs for minors diagnosed with mental health issues. She discussed her findings with [New York Times] columnist and author of [Perfect Madness], Judith Warner. http://www.c-spanvideo.org/program/305955-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/305955-1 Sat, 20 Apr 2013 00:00:00 GMT Ms. Rosenberg exposes what goes on behind the scenes in the food and drug industries. With the help of doctors, experts, and researchers, she reveals regulatory lapses and what she calls government complicity in undermining the public health. She discussed her findings with Stephanie Beasley, an associate editor of [FDA Week]. http://www.c-spanvideo.org/program/306479-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/306479-1 Sat, 20 Apr 2013 00:00:00 GMT The Justice Department announced a historical health care fraud settlement with GlaxoSmithKline. The $3 billion settlement was the largest of its kind and resulted from multiple criminal and civil investigations involving the drugs Paxil, Wellbutrin, and Avandia. http://www.c-spanvideo.org/program/306889-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/306889-1 Sat, 20 Apr 2013 00:00:00 GMT Allan Coukell, deputy director of the Medical Safety Portfolio of the Pew Health Group, talked about the drug safety. Earlier in the week, the House passed the Food and Drug Administration Reform Act of 2012 by a vote of 387-5. This legislation gives the FDA the funding it needs to approve new drugs and medical devices more quickly and improves inspection. The Senate passed a similar bill the previous week and a final draft of legislation is expected early the next month. Mr. Coukell responded to telephone calls and electronic communications. http://www.c-spanvideo.org/program/306374-5 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/306374-5 Sat, 20 Apr 2013 00:00:00 GMT Harriet Washington argues that a growing corporate presence in the medical industry yields dire consequences for patients, as drug development and research is initiated on a for-profit basis. Ms. Washington's contentions of the industry's fiscal motivations include the reported versus the actual cost of bringing a new drug to market, her estimate that the monetary value of gifts given by corporate drug manufacturers to physicians in 2000 was $6 billion, and the restricted nature of medical patents, which, the author contends suppresses research. Harriet Washington showed slides throughout her presentation, and then responded to questions from members of the audience at the University of Georgia in Athens, Georgia. http://www.c-spanvideo.org/program/305728-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/305728-1 Sat, 20 Apr 2013 00:00:00 GMT Merck Pharmaceuticals Chief Executive Officer Kenneth Frazier was interviewed by Alan Murray about health care and the pharmaceutical industry. Among the topics they discussed were the 2010 health care law, Food and Drug Administration drug approval, and the the Penn State sexual abuse case, of which Mr. Frazier was in charge. The program included questions and answers with audience members. http://www.c-spanvideo.org/program/303168-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/303168-1 Sat, 20 Apr 2013 00:00:00 GMT Government and private sector officials testified on the use of antipsychotic drugs on dementia patients in nursing homes and long term care facilities. The Food and Drug Administration has said these drugs could cause serious or life threatening adverse effects. Topics included staff training, increased familial involvement, and better collaboration and communication during the transfer stage from a hospital to a nursing home or long-term care facility. http://www.c-spanvideo.org/program/302927-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/302927-1 Sat, 20 Apr 2013 00:00:00 GMT President Obama signed an executive order aimed at preventing shortages of prescription drugs. The order broadens reporting of potential shortages of certain prescription drugs, speeds reviews of applications to begin or alter production of these drugs, and provides more information to the Justice Department about possible instances of collusion or price gouging. http://www.c-spanvideo.org/program/302406-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/302406-1 Sat, 20 Apr 2013 00:00:00 GMT Peter Hirth talked about he pharmaceutical industry, including the process for getting a drug approved by the FDA. Guest has invented several drugs including Sutent for kidney cancer and Zelboraf for melanoma. He responded to telephone calls and electronic communications. Mr. Hirth participated from San Francisco. Due to a signal loss, the program begins in progress, and approximately eight minutes of the program were lost. Part one can viewed using program identification number 302145-5. http://www.c-spanvideo.org/program/302145-101 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/302145-101 Sat, 20 Apr 2013 00:00:00 GMT Peter Hirth talked about the pharmaceutical industry, including the process for getting a drug approved by the FDA. Guest has invented several drugs including Sutent for kidney cancer and Zelboraf for melanoma. He responded to telephone calls and electronic communications. Mr. Hirth participated from San Francisco. Due to a signal loss, the program ends abruptly, and approximately eight minutes of the program were lost. Part two can viewed using program identification number 302145-101. http://www.c-spanvideo.org/program/302145-5 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/302145-5 Sat, 20 Apr 2013 00:00:00 GMT Doctors and officials from Health and Human Services and the Food and Drug Administration testified on the effects of drug shortages on cancer patients. http://www.c-spanvideo.org/program/301725-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/301725-1 Sat, 20 Apr 2013 00:00:00 GMT The House Judiciary Subcommittee on Competition held a hearing examining the proposed merger between pharmacy benefit management companies Express Scripts and Medco Health Solutions. Among the issues they addressed were antitrust concerns about the merger, prescription drug costs, and the potential impact on community pharmacies. The proposed merger would create a company involved in about a third of the prescription drug transactions in the U.S. http://www.c-spanvideo.org/program/301656-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/301656-1 Sat, 20 Apr 2013 00:00:00 GMT Allan Coukell talked about the Governmental Accountability Office (GAO) report on the make-up of prescription drugs, and he responded to telephone calls and electronic communications. According the findings of the report, up to 80 percent of the chemicals and ingredients in the drugs were made outside the U.S. Mr. Coukell, who testified at a recent Senate hearing on the issue, discussed the oversight of the pharmaceutical industry, and the risk that foreign components in drugs present to individuals in the U.S. http://www.c-spanvideo.org/program/301607-4 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/301607-4 Sat, 20 Apr 2013 00:00:00 GMT Witnesses testified on the safety of pharmaceuticals made fully or partially abroad. A Government Accountability Office (GAO) report indicated that 80 percent of U.S. drug ingredients, and 40 percent of finished drugs were made abroad. Among the topics addressed were Food and Drug Administration (FDA) rules for drug quality assurance and inspections, tracking systems, and drug recalls. http://www.c-spanvideo.org/program/301530-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/301530-1 Sat, 20 Apr 2013 00:00:00 GMT Gardiner Harris talked about Food and Drug Administration (FDA) estimate that close to 180 important drugs are in short-supply. In response, health providers are being forced to purchase expensive alternative drugs. Guest will discuss the reasons behind the shortfall and some of the proposals for correcting the problem, which include a national stockpiling of select drugs, incentives for increased production of generic drugs and more authority for the FDA to ensure that adequate supplies exist. He responded to telephone calls and electronic communications. http://www.c-spanvideo.org/program/301255-5 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/301255-5 Sat, 20 Apr 2013 00:00:00 GMT Douglas Holtz-Eakin talked about Medicare Part D as part of overall discussions on the debt between President Obama and congressional leaders, and he responded to telephone calls and electronic communications. Part D is the portion of Medicare that deals with prescription drugs. President Obama and Democrats would like to see changes to Part D. Among their proposals is to require drug companies to extend rebates for drugs issued under Medicare Part D. Currently, drug companies only have to issue rebates for drugs under Medicaid. http://www.c-spanvideo.org/program/300671-4 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/300671-4 Sat, 20 Apr 2013 00:00:00 GMT Michael Willrich examined the smallpox epidemic in America in the early 1900s. The author detailed the government's initiatives to deter the spread of the disease by requiring mandatory vaccinations and instituting "virus squads" that upheld quarantines. Though these measures eventually contained the disease, they also sparked a wave of popular resistance among Americans who perceived them as a threat to their health and to their rights. Mr. Willrich addressed the questions of how far the government should go to protect the people and what happens when the interests of public health collide with religious beliefs and personal conscience. He responded to questions from members of the audience. http://www.c-spanvideo.org/program/300232-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/300232-1 Sat, 20 Apr 2013 00:00:00 GMT A community prevention manager of the Rhode Island Student Assistance Services and the director of the prescription monitoring program at Brandeis University testified on the problem of prescription drug abuse and discussed proposed solutions. http://www.c-spanvideo.org/program/299668-2 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/299668-2 Sat, 20 Apr 2013 00:00:00 GMT White House and Drug Enforcement Administration officials testified on the problem of prescription drug abuse and proposed solutions. Senator Sherrod Brown also testified on his bill, the "Stop Trafficking of Pills" Act. http://www.c-spanvideo.org/program/299668-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/299668-1 Sat, 20 Apr 2013 00:00:00 GMT Obama administration officials unveiled an aggressive plan to curb prescription drug abuse. The plan will include some new federal requirements aimed at educating the medical community about the proper use of prescription drugs. There are four main parts to the administration's initiative: education, monitoring, taking unused prescription drugs back and enforcement of drug laws. http://www.c-spanvideo.org/program/299124-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/299124-1 Sat, 20 Apr 2013 00:00:00 GMT Arthur Ainsberg talked about his book [Breakthrough: Elizabeth Hughes, the Discovery of Insulin, and the Making of a Medical Miracle] (St. Martin's Press, 2010), which recounts the development of insulin to treat diabetes. The author recounts the case of Elizabeth Hughes, who at eleven-years-old in 1919 was diagnosed with juvenile diabetes and was treated by starvation. Ms. Hughes would be one of the first patients treated with insulin injections due to the discovery of purified insulin from animal pancreases by Canadians Frederick Banting and Charles Best. Dr. Michael Bergman then spoke about the history of the types of insulin and syringes. Their talks were illustrated by slides. A brief video was shown of Jean Ashton and Stephen Edidin of the New York Historical Society talking about the "[Breakthrough] Exhibit" based on the book that they then had on display. A video from dLife featuring Professor Michael Bliss and early users of insulin Bob and Gerald Cleveland as well as many others was also shown. Dr. Jesse Roth commented on the presentations. Then the panelists responded to questions from members of the audience. This was an event at the New York University School of Medicine in New York City. http://www.c-spanvideo.org/program/297735-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/297735-1 Sat, 20 Apr 2013 00:00:00 GMT Paul Offit takes a broad look at the anti-vaccine movement in the United States and its consequences for children and adults. Dr. Offit spoke at the Harvard Club in New York City at an event hosted by the Manhattan Institute. http://www.c-spanvideo.org/program/297920-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/297920-1 Sat, 20 Apr 2013 00:00:00 GMT Panelists talked about efforts and progress in fighting counterfeit perscription drugs. They used slides during their presentations, and afterward the panelists responded to questions from members of the audience. Tom Kubic moderated. "Who's Making Progress Against Counterfeit Drugs?" was the third panel of the Counterfeit Drug Forum held by the Partnership for Safe Medicines at the National Press Club. http://www.c-spanvideo.org/program/295894-3 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/295894-3 Sat, 20 Apr 2013 00:00:00 GMT Panelists talked about who benefits from unsafe drugs. Topics included enforcement and prosecution efforts and difficulties, and the trafficking of controlled prescription drugs such as Oxycontin. The panelists responded to questions from members of the audience. Dr. Bryan Liang moderated. "Who's Benefiting from Unsafe Drugs?" was the second panel of the Counterfeit Drug Forum held by the Partnership for Safe Medicines at the National Press Club. http://www.c-spanvideo.org/program/295894-2 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/295894-2 Sat, 20 Apr 2013 00:00:00 GMT Food and Drug Administration (FDA) Commissioner Margaret Hamburg gave her assessment of the problem of counterfeit drugs and talked about what the FDA is doing to combat it. She responded to questions from members of the audience. This was the keynote speech at the Counterfeit Drug Forum held by the Partnership for Safe Medicines at the National Press Club. Marv Shepherd then gave the closing remarks for the day. http://www.c-spanvideo.org/program/295894-4 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/295894-4 Sat, 20 Apr 2013 00:00:00 GMT The Partnership for Safe Medicines held a forum on counterfeit prescription drugs. Scott LaGanga opened the discussion with an overview of the issue. Marv Shepherd moderated the panel, which included an AIDS patient who accidentally used counterfeit drugs to treat his symptoms. Following their remarks, panelists responded to audience members' questions. "Who's Getting Hurt by Counterfeit Drugs?" was the opening panel of the Counterfeit Drug Forum held by the Partnership for Safe Medicines at the National Press Club. http://www.c-spanvideo.org/program/295894-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/295894-1 Sat, 20 Apr 2013 00:00:00 GMT Catherine Larkin talked about the FDA's drug approval and review processes for current drugs on the market. She responded to telephone calls and electronic communications. Among the topics she addressed were the recall of the diabetes medicine Avandia and the rejection of the weight loss drug, Qnexa. http://www.c-spanvideo.org/program/294663-7 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/294663-7 Sat, 20 Apr 2013 00:00:00 GMT Dr. Anthony Fauci talked about antibiotic resistance due to to the overuse of antibiotics. He responded to telephone calls and electronic communications. http://www.c-spanvideo.org/program/293385-5 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/293385-5 Sat, 20 Apr 2013 00:00:00 GMT Historian Elaine Tyler May chronicles the history of the birth control pill. Professor May argues that "the Pill" had two mothers: birth control pioneer Margaret Sanger and women's rights activist Katharine McCormick. She argues that the most important change brought about by "the Pill" was for married couples, making it possible for women to plan careers. Elaine May was interviewed by American Enterprise Institute scholar Christina Hoff Sommers. The date and location of this program is not known. http://www.c-spanvideo.org/program/293208-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/293208-1 Sat, 20 Apr 2013 00:00:00 GMT The New York Times columnist explores health insurance coverage for behavioral disorders in children, such as ADHD, Asperger's, OCD, bi-polar disorder and dyslexia. She discusses how parents attempt to obtain proper treatment for their children in a health care system that does not seemed designed to handle or pay for treatment for these disorders, in addition to treatment for physical ailments. http://www.c-spanvideo.org/program/292445-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/292445-1 Sat, 20 Apr 2013 00:00:00 GMT Andrew Pekosz talked about the safety of the H1N1 influenza vaccine, who should get it, the benefits of the shot versus the nose mist, when the vaccine will become available, the shortfall in manufacturing the vaccine, as well as any side effects of the vaccine. Topics included who is being infected by the virus and how to handle it in conjunction with the regular seasonal influenza. Scenes of vaccinations being given were shown in the background. He responded to telephone calls and electronic communications. The program concluded by showing recent editorial cartoons. http://www.c-spanvideo.org/program/289509-4 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/289509-4 Sat, 20 Apr 2013 00:00:00 GMT Witnesses testified about proposed legislation that would restrict approval and use of antimicrobial drugs for animals. The legislation would ban seven classes of antibiotics important to human health from being used in animals, and would restrict other antibiotics to therapeutic and some preventive uses. Officials called for ending the use of antibiotics for growth promotion in hogs and other livestock, saying the overuse of antibiotics on farms could lead to drugs losing their effectiveness in human medicine. http://www.c-spanvideo.org/program/287677-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/287677-1 Sat, 20 Apr 2013 00:00:00 GMT The panel talked about the state of science in relation to mental illness. They focused on the development of procedures, techniques, and trends. Dr. Sanjay Gupta moderated the panel. http://www.c-spanvideo.org/program/286992-4 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/286992-4 Sat, 20 Apr 2013 00:00:00 GMT Representatives of insurance companies and the government discussed President Obama's health care policies. The panelists focused on President Obama's emphasis on preventative care, retraining programs, and community medical centers. The panelists answered questions from the audience. http://www.c-spanvideo.org/program/285252-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/285252-1 Sat, 20 Apr 2013 00:00:00 GMT Representative Timothy Murphy talked about today's House Energy and Commerce hearing on the Salmonella outbreak, and he responded to telephone calls and electronic mail. He also discussed the oversight of the FDA and what he feels needs to be done to improve the safety of foods and drugs. http://www.c-spanvideo.org/program/280156-4 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/280156-4 Sat, 20 Apr 2013 00:00:00 GMT A hearing was held to examine the increasing use of prescription controlled substances by teenagers and others for non-medical purposes, which has been exacerbated by the ease of obtaining them over the Internet. Topics included the nature and cause of the problem, the extent to which the problem originates outside the U.S., how to fight rogue sites without disrupting legitimate sites, and whether current laws can sufficiently address the problem. http://www.c-spanvideo.org/program/206149-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/206149-1 Sat, 20 Apr 2013 00:00:00 GMT Charles Barber responded to telephone calls from viewers about his book [Comfortably Numb: How Psychiatry Is Medicating a Nation]. In the book he contends that Americans are overmedicated and have confused the difference between ordinary problems and mental illness. http://www.c-spanvideo.org/program/204503-1 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/204503-1 Sat, 20 Apr 2013 00:00:00 GMT Dr. Andrew Von Eschenbach talked about the Food and Drug Administration oversight of drugs, the drug approval and inspection process, and whether current funding levels are negatively impacting the process. Recent developments involving the blood thinner Heparin have led to questions about the FDA's inspection of foreign-manufactured drugs entering the U.S. Dr. Von Eschenbach responded to telephone calls and electronic mail. He also responded to student telephone calls from Paul Laurence Dunbar High School in Lexington, Kentucky. http://www.c-spanvideo.org/program/203403-5 info@c-spanarchives.org (National Cable Satellite Corporation) http://www.c-spanvideo.org/program/203403-5 Sat, 20 Apr 2013 00:00:00 GMT